clofibric acid has been researched along with Amentia in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overall 32." | 1.33 | APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. ( Alpérovitch, A; Amouyel, P; Dartigues, JF; Dufouil, C; Fiévet, N; Richard, F; Ritchie, K; Tzourio, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dufouil, C | 1 |
| Richard, F | 1 |
| Fiévet, N | 1 |
| Dartigues, JF | 1 |
| Ritchie, K | 1 |
| Tzourio, C | 1 |
| Amouyel, P | 1 |
| Alpérovitch, A | 1 |
1 other study available for clofibric acid and Amentia
| Article | Year |
|---|---|
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Apolipoproteins E; Causality; Cholesterol; Clofibric Aci | 2005 |